EP0039874A3 - Methoxsalenzusammensetzungen und deren Herstellung - Google Patents

Methoxsalenzusammensetzungen und deren Herstellung Download PDF

Info

Publication number
EP0039874A3
EP0039874A3 EP81103364A EP81103364A EP0039874A3 EP 0039874 A3 EP0039874 A3 EP 0039874A3 EP 81103364 A EP81103364 A EP 81103364A EP 81103364 A EP81103364 A EP 81103364A EP 0039874 A3 EP0039874 A3 EP 0039874A3
Authority
EP
European Patent Office
Prior art keywords
methoxsalen
compositions
preparation
psoriasis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP81103364A
Other languages
English (en)
French (fr)
Other versions
EP0039874A2 (de
Inventor
Richard H. Barry
Jack H. Lazarus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of EP0039874A2 publication Critical patent/EP0039874A2/de
Publication of EP0039874A3 publication Critical patent/EP0039874A3/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP81103364A 1980-05-07 1981-05-05 Methoxsalenzusammensetzungen und deren Herstellung Withdrawn EP0039874A3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14769780A 1980-05-07 1980-05-07
US147697 1980-05-07

Publications (2)

Publication Number Publication Date
EP0039874A2 EP0039874A2 (de) 1981-11-18
EP0039874A3 true EP0039874A3 (de) 1982-08-04

Family

ID=22522553

Family Applications (1)

Application Number Title Priority Date Filing Date
EP81103364A Withdrawn EP0039874A3 (de) 1980-05-07 1981-05-05 Methoxsalenzusammensetzungen und deren Herstellung

Country Status (10)

Country Link
EP (1) EP0039874A3 (de)
JP (1) JPS572217A (de)
AU (1) AU545363B2 (de)
CA (1) CA1173751A (de)
DK (1) DK193381A (de)
IE (1) IE51243B1 (de)
IL (1) IL62762A (de)
NZ (1) NZ196973A (de)
PH (1) PH18681A (de)
ZA (1) ZA812884B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85829A1 (fr) * 1985-04-01 1986-11-05 Cird Composition pour bains a base de psoralene dans le traitement du psoriasis
GB2318291B (en) * 1996-10-15 1998-09-23 Robin Morley 8-Methoxypsoralen containing additives for topical application in bath water

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2256765A1 (de) * 1974-01-09 1975-08-01 Bayer Ag
FR2268517A1 (de) * 1974-04-24 1975-11-21 Hoechst Ag
GB2052980A (en) * 1979-06-25 1981-02-04 Gerot Pharmazeutika Pharmaceutical composition for oral administration comprising methoxsalen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2256765A1 (de) * 1974-01-09 1975-08-01 Bayer Ag
FR2268517A1 (de) * 1974-04-24 1975-11-21 Hoechst Ag
GB2052980A (en) * 1979-06-25 1981-02-04 Gerot Pharmazeutika Pharmaceutical composition for oral administration comprising methoxsalen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 86, no. 11, 14th March 1977, page 118, no. 66414v, Columbus, Ohio, USA, R. SUHONEN: "Phototoxicity of methoxsalen in various vehicles", & CONTACT DERMATITIS 1976, 2(5), 264-268. *
L. VIDAL: "Dictionnaire VIDAL", 55th Edition, OVP 1979, Paris, FR; pages 1260-1261, "Meladinine" *

Also Published As

Publication number Publication date
EP0039874A2 (de) 1981-11-18
IL62762A (en) 1985-02-28
IL62762A0 (en) 1981-06-29
NZ196973A (en) 1984-12-14
IE51243B1 (en) 1986-11-12
AU545363B2 (en) 1985-07-11
ZA812884B (en) 1982-05-26
AU7006981A (en) 1981-11-12
IE811000L (en) 1981-11-07
JPS572217A (en) 1982-01-07
PH18681A (en) 1985-08-29
DK193381A (da) 1981-11-08
CA1173751A (en) 1984-09-04

Similar Documents

Publication Publication Date Title
JPS57112359A (en) Carboxylalkyl dipeptide, manufacture and medicinal composition
JPS5794018A (en) Polyethylene glycol derivative and cosmetic and medicinal composition
IL62694A0 (en) Aminothiadiazole derivatives,their preparation and pharmaceutical compositions containing them
DE3173310D1 (en) Pharmaceutical compositions for promoting the healing of wounds
ATE32430T1 (de) Pharmazeutische zusammensetzungen.
ZA818371B (en) Nortropanols,their preparation and pharmaceutical compositions containing these
AU581853B2 (en) Coumarin derivatives, pharmaceutical compositions containing the same, and the use thereof in the treatment of cancer
AU1583383A (en) Tooth treatment composition
IL67940A0 (en) 2,3-diaryl-5-halo-thiophenes,their preparation and pharmaceutical compositions containing them
AU8732182A (en) Pharmaceutical compositions for the treatment of skin
IL63773A (en) Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide,its preparation and pharmaceutical compositions containing it
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
IL69593A (en) Pilocarpine prodrugs,their preparation and pharmaceutical compositions containing them
IL67925A0 (en) Laevorotatory isomer of mequitazine,its preparation and pharmaceutical compositions containing it
IE811000L (en) Methoxsalen composition
AU576739B2 (en) 2-piperazinyl-or-homo-piperazinyl-quinazoline derivatives and pharmaceutical compositions
JPS5721354A (en) Esters of carnitine alkoxy-acyl derivatives, manufacture and medicinal composition as effective component thereof
IL63594A0 (en) Cytostatic compounds,their preparation and pharmaceutical compositions containing them
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
EP0351876A3 (de) Zusammensetzung zur Steigerung der Impfungswirkung
ES8302457A1 (es) Un procedimiento para preparar soluciones acu0sas a base de una sal de sulfonamida acuosoluble, un potenciador de sulfo-namida y un aldehido.
JPS5724339A (en) Alkoxy-acylcarnitine, manufacture and medicinal composition as effective component thereof
DE3368889D1 (en) Pesticide compositions for the treatment of wood
JPS5748915A (en) Tumor inhibiting pharmaceutical composition and use thereof
EP0356192A3 (de) Verhütung und Behandlung von Lebergeschwüren bei Tieren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LU NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT LU NL SE

17P Request for examination filed

Effective date: 19810505

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19840326

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LAZARUS, JACK H.

Inventor name: BARRY, RICHARD H.